Market Overview

US Stock Futures Down; ADP Report In Focus

Share:
US Stock Futures Down; ADP Report In Focus
Related TSLA
Why Mobileye Investors Could Be The Biggest Winners In The Autonomous Auto Race
10 Companies Apple Almost Bought In The Past 10 Years
Tesla Stock Shows Weakness As It Takes On Ambitious Goals (Investor's Business Daily)
Related RCAP
10% Annual Alpha? Why Pair Trades Make Sense When The Market Is Volatile
RCS Capital Corporation Announces Changes to Board of Directors

Pre-open movers

US stock futures fell in early pre-market trade. The ADP national employment report for September will be released at 8:15 a.m. ET. Futures for the Dow Jones Industrial Average tumbled 83 points to 15,037.00, while the Standard & Poor's 500 index futures fell 12.10 points to 1,677.30. Futures for the Nasdaq 100 index dropped 18 points to 3,227.50.

A Peek Into Global Markets

European markets were lower today, with the Spanish Ibex Index falling 0.35%, London's FTSE 100 index dropping 0.87% and STOXX Europe 600 Index declining 0.61%. German DAX 30 index fell 0.62% and French CAC 40 Index declined 0.74%. UK construction PMI fell to 58.90 in September, from a prior reading of 59.10.

Asian markets ended mostly higher today. Japan's Nikkei Stock Average fell 2.17%, Australia's ASX/S&P500 gained 0.17% and Hong Kong's Hang Seng Index surged 0.55%. Australia's trade deficit narrowed to A$815 million in August, from a deficit of A$1.4 billion in July.

Broker Recommendation

Analysts at Baird downgraded Tesla Motors (NASDAQ: TSLA) from “buy” to “neutral.” The target price for Tesla Motors is set to $187.

Tesla's shares dropped 2.78% to $187.64 in pre-market trading.

Breaking news

  • RCS Capital (NYSE: RCAP) and Investors Capital Holdings (NYSE: ICH) announced today that they have entered into a letter of intent relating to the acquisition by RCAP of ICH. To read the full news, click here.
  • Synergy Pharmaceuticals (NASDAQ: SGYP) today announced plans to move forward this quarter with SP-333, its proprietary next-generation guanylate cyclase-C (GC-C) agonist, into a phase 2 study for the treatment of opioid-induced constipation (OIC). To read the full news, click here.
  • Allot Communications (NASDAQ: ALLT) today announced it has received a new multimillion dollar order from a U.S.-based, multinational cloud provider for its Deep Packet Inspection-enabled Service Gateway solution. To read the full news, click here.
  • Profitero, the leading global provider of online competitor pricing data, today announced that Staples (NASDAQ: SPLS) has chosen to partner with Profitero for price monitoring and collection across multiple European countries. To read the full news, click here.

Posted-In: Baird US Stock FuturesNews Eurozone Futures Global Pre-Market Outlook Markets

 

Related Articles (ICH + ALLT)

View Comments and Join the Discussion!